Junior Explorer Jumps on Gold Sample Results

Max Resource Corp. (TSXV:MXR), a junior explorer, powered higher after announcing surface assay results from its Choco Project in Colombia

Sean Mason | April 16, 2019 | SmallCapPower

Surface assay results generated much speculation in shares of a junior explorer Tuesday. Here’s some small stocks making big moves on Tuesday, April 16, 2019 (as of 4 pm EST):

Max Resource Corp. (TSXV:MXR) shares gained as much as 25% on Tuesday after the junior explorer announced surface assay results from ongoing exploration on its Choco Gold and Platinum Project in Colombia, with one sample grading 340.84 g/t gold and 111.03 g/t platinum.

Win Big With Our Small Cap Picks


As well, shares of Sokoman Minerals Corp. (TSXV:SIC) plunged 42% to $0.11 as the gold explorer released assay results from Phase 3 diamond drilling at its Moosehead Gold Project in Newfoundland, which included 4.8 metres of 33.59 g/t gold starting at a downhole depth of 239.85 metres.

MediPharm Labs Corp. (TSXV:LABS), meanwhile, reported that it has received Depository Trust Company eligibility for its common shares in the United States. MediPharm Labs stock moved up 4% to $5.89 following the announcement.

Did you know that Ubika Alpha initiated coverage of MediPharm Labs shares on January 18, 2019 at a price of $1.96? Read the original report here

Finally, Aleafia Health Inc. (TSX:ALEF) shares rose as much as 7% after the medical cannabis company announced that it will add 50,000 kg of extraction capacity with the Phase II expansion of the Company’s processing facility in Paris, ON.

Aleafia Health Inc. (TSX:ALEF) and Max Resource Corp. (TSXV:MXR) are featured sponsored companies and have paid SmallCapPower.com a fee for coverage. To learn more, see our full disclosure HERE >>

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: